Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NNZ-2566: Phase IIa start

In mid-2008, NEU will begin a double-blind, placebo-controlled Phase IIa trial in

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE